Interv Akut Kardiol. 2018;17(2):85-91 | DOI: 10.36290/kar.2018.043

Catheter ablation of ventricular tachycardia in structural heart disease: current perspectives

Petr Peichl, Josef Kautzner
Klinika kardiologie, Institut klinické a experimentální medicíny, Praha

As in other arrhythmias, the strategies for ablation of ventricular tachycardias (VTs) in patients with structural heart disease areevolving. The current dominant strategy is substrate ablation, because it is associated with better outcomes than conventionalapproach and activation mapping during VT. The progress in imaging has enabled a more detailed characterization of the arrhythmogenicsubstrate in these patients. Likewise, novel techniques of ablation have been proposed that allow modification ofthe substrate in previously inaccessible sites. Despite the improvements, treatment of these patients still represents a challenge.For patients with an arrhythmic storm, successful ablation may be a life-saving procedure. Our aim is to review the current perspectivesof catheter ablation of VT in patients with structural heart disease.

Keywords: ventricular tachycardia, ventricular fibrillation, catheter ablation

Published: May 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Peichl P, Kautzner J. Catheter ablation of ventricular tachycardia in structural heart disease: current perspectives. Interv Akut Kardiol. 2018;17(2):85-91. doi: 10.36290/kar.2018.043.
Download citation

References

  1. Priori SG, Blomström-Lundqvist C, Mazzanti, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 2015; 36: 2793-2867. Go to original source... Go to PubMed...
  2. Haissaguerre M, Ha?ssaguerre M, Shoda M, et al. Mapping and ablation of idiopathic ventricular fibrillation. Circulation 2002; 106: 962-967. Go to original source... Go to PubMed...
  3. Peichl P, Cihák R, Kozeluhová M, Wichterle D, Vancura V, Kautzner J. Catheter ablation of arrhythmic storm triggered by monomorphic ectopic beats in patients with coronary artery disease. J Inter Card Electrophysiol 2010; 27: 51-59. Go to original source... Go to PubMed...
  4. Marchlinski FE, Callans DJ, Gottlieb CD, Zado E. Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. Circulation 2000; 101: 1288-1296. Go to original source... Go to PubMed...
  5. Arenal A, del Castillo S, Gonzalez-Torrecilla E, et al. Tachycardia-related channel in the scar tissue in patients with sustained monomorphic ventricular tachycardias: influence of the voltage scar definition. Circulation 2004; 110: 2568-2574. Go to original source... Go to PubMed...
  6. Silberbauer J, Oloriz T, Maccabelli G, et al. Noninducibility and late potential abolition: a novel combined prognostic procedural end point for catheter ablation of postinfarction ventricular tachycardia. Circ Arrhythm Electrophysiol 2014; 7: 424-435. Go to original source... Go to PubMed...
  7. Ja?s P, Maury P, Khairy P, et al. Elimination of local abnormal ventricular activities: a new end point for substrate modification in patients with scar-related ventricular tachycardia. Circulation 2012; 125: 2184-2196. Go to original source... Go to PubMed...
  8. Komatsu Y, Daly M, Sacher F, et al. Endocardial ablation to eliminate epicardial arrhythmia substrate in scar-related ventricular tachycardia. J Am Coll Cardiol 2014; 63: 1416-1426. Go to original source... Go to PubMed...
  9. Di Biase L, Burkhardt JD, Lakkireddy D, et al. Ablation of stable VTs versus substrate ablation in ischemic cardiomyopathy: the VISTA randomized multicenter trial. J Am Coll Cardiol 2015; 66: 2872-2882. Go to original source... Go to PubMed...
  10. Palaniswamy C, Miller MA, Reddy VY, Dukkipati SR. Hemodynamic support for ventricular tachycardia ablation. Card Electrophysiol Clin 2017; 9: 141-152. Go to original source... Go to PubMed...
  11. Kusa S, Miller MA, Whang W, et al. Outcomes of ventricular tachycardia ablation using percutaneous left ventricular assist devices. Circ Arrhythmia Electrophysiol 2017; 10: e004717. Go to original source... Go to PubMed...
  12. Romero J, Di Biase L. Percutaneous ventricular assist devices for catheter ablation of ventricular tachycardia in structural heart disease: "A Conditio Sine Qua Non"? J Cardiovasc Electrophysiol 2017; 28: 1303-1305. Go to original source... Go to PubMed...
  13. Piers SRD, Tao Q, van Huls, et al. Contrast-enhanced MRI-derived scar patterns and associated ventricular tachycardias in nonischemic cardiomyopathy: implications for the ablation strategy. Circ Arrhythm Electrophysiol 2013; 6: 875-883. Go to original source... Go to PubMed...
  14. Dickfeld T, Tian J, Ahmad G, et al. MRI-Guided ventricular tachycardia ablation: integration of late gadolinium-enhanced 3D scar in patients with implantable cardioverter-defibrillators. Circ Arrhythm Electrophysiol 2011; 4: 172-184. Go to original source... Go to PubMed...
  15. Perez-David E, Arenal A, Rubio-Guivernau JL, et al. Noninvasive identification of ventricular tachycardia-related conducting channels using contrast-enhanced magnetic resonance imaging in patients with chronic myocardial infarction: comparison of signal intensity scar mapping and endocardial voltage mapping. J Am Coll Cardiol 2011; 57: 184-194. Go to original source... Go to PubMed...
  16. Cochet H, Komatsu Y, Sacher F, et al. Integration of merged delayed-enhanced magnetic resonance imaging and multidetector computed tomography for the guidance of ventricular tachycardia ablation: a pilot study. J Cardiovasc Electrophysiol 2013; 24: 419-426. Go to original source... Go to PubMed...
  17. Esposito A, Palmisano A, Antunes S, et al. Cardiac CT with delayed enhancement in the characterization of ventricular tachycardia structural substrate: relationship between CT-segmented scar and electro-anatomic mapping. JACC Cardiovasc Imaging 2016; 9: 822-832. Go to original source... Go to PubMed...
  18. Hussein A, Jimenez A, Ahmad G, et al. Assessment of ventricular tachycardia scar substrate by intracardiac echocardiography. Pacing Clin Electrophysiol 2014; 37: 412-421. Go to original source... Go to PubMed...
  19. Peichl P, Wichterle D, Čihák R, Aldhoon B, Kautzner J. Catheter ablation of ventricular tachycardia in the presence of an old endocavitary thrombus guided by intracardiac echocardiography. Pacing Clin Electrophysiol 2016; 39: 581-587. Go to original source... Go to PubMed...
  20. Grieco D, Peichl P, Čihák R, Kautzner J. Successful ablation of ventricular tachycardia after correction of tetralogy of Fallot. Herzschrittmachertherapie + Elektrophysiologie 2014; 25: 116-120. Go to original source... Go to PubMed...
  21. Stevenson WG, Wilber DJ, Natale A, et al. Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial. Circulation 2008; 118: 2773-2782. Go to original source... Go to PubMed...
  22. Marchlinski FE, Haffajee CI, Beshai JF, et al. Long-term success of irrigated radiofrequency catheter ablation of sustained ventricular tachycardia: post-approval THERMOCOOL VT Trial. J Am Coll Cardiol 2016; 67: 674-683. Go to original source... Go to PubMed...
  23. Reddy VY, Reynolds MR, Neuzil P, et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. NEJM 2007; 357: 2657-2665. Go to original source... Go to PubMed...
  24. Kuck K, Schaumann A, Eckardt L, et al. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet 2010; 375: 31-40. Go to original source... Go to PubMed...
  25. Kuck K-H, Tilz RR, Deneke T, et al. Impact of substrate modification by catheter ablation on implantable cardioverter-defibrillator interventions in patients with unstable ventricular arrhythmias and coronary artery disease: results from the multicenter randomized controlled SMS (Substrate Modification Study). Circ Arrhythm Electrophysiol 2017; 10: e004422. Go to original source... Go to PubMed...
  26. Carbucicchio C, Santamaria M, Trevisi N, et al. Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short - and long-term outcomes in a prospective single-center study. Circulation 2008; 117: 462-469. Go to original source... Go to PubMed...
  27. Della Bella P, Baratto F, Tsiachris D, Trevisi N, et al. Management of ventricular tachycardia in the setting of a dedicated unit for the treatment of complex ventricular arrhythmias: long-term outcome after ablation. Circulation 2013; 127: 1359-1368. Go to original source... Go to PubMed...
  28. Tung R, Vaseghi M, Frankel DS, et al. Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: An International VT Ablation Center Collaborative Group study. Hear Rhythm 2015; 12: 1997-2007. Go to original source... Go to PubMed...
  29. Nayyar S, Ganesan AN, Brooks AG, Sullivan T, Roberts-Thomson KC, Sanders P. Venturing into ventricular arrhythmia storm: a systematic review and meta-analysis. Eur Heart J 2013; 34: 560-571. Go to original source... Go to PubMed...
  30. Aldhoon B, Wichterle D, Peichl P, Čihák R, Kautzner J. Outcomes of ventricular tachycardia ablation in patients with structural heart disease: The impact of electrical storm. PLoS One 2017; 12: e0171830. Go to original source... Go to PubMed...
  31. Sosa E, Scanavacca M. Epicardial mapping and ablation techniques to control ventricular tachycardia. J Cardiovasc Electrophysiol 2005; 16: 449-452. Go to original source... Go to PubMed...
  32. Della Bella P, Brugada J, Zeppenfeld K, et al. Epicardial ablation for ventricular tachycardia: a European multicenter study. Circ Arrhythmia Electrophysiol 2011; 4: 653-659. Go to original source... Go to PubMed...
  33. Polin GM, Haqqani H, Tzou W, et al. Endocardial unipolar voltage mapping to identify epicardial substrate in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Hear Rhythm 2011; 8: 76-83. Go to original source... Go to PubMed...
  34. Hutchinson MD, Gerstenfeld EP, Desjardins B, et al. Endocardial unipolar voltage mapping to detect epicardial ventricular tachycardia substrate in patients with nonischemic left ventricular cardiomyopathy. Circ Arrhythmia Electrophysiol 2011; 4: 49-55. Go to original source... Go to PubMed...
  35. Berruezo A, Mont L, Nava S, Chueca E, Bartholomay E, Brugada J. Electrocardiographic recognition of the epicardial origin of ventricular tachycardias. Circulation 2004; 109: 1842-1847. Go to original source... Go to PubMed...
  36. Bala R, Ren J-F, Hutchinson MD, et al. Assessing epicardial substrate using intracardiac echocardiography during VT ablation. Circ Arrhythm Electrophysiol 2011; 4: 667-673. Go to original source... Go to PubMed...
  37. Koruth JS, Dukkipati S, Miller MA, Neuzil P, d'Avila A, Reddy VY. Bipolar irrigated radiofrequency ablation: a therapeutic option for refractory intramural atrial and ventricular tachycardia circuits. Hear Rhythm 2012; 9: 1932-1941. Go to original source... Go to PubMed...
  38. Sapp JL, Cooper JM, Soejima K, et al. Deep myocardial ablation lesions can be created with a retractable needle-tipped catheter. Pacing Clin Electrophysiol 2004; 27: 594-599. Go to original source... Go to PubMed...
  39. Kreidieh B, Rodríguez-Ma?ero MA, Schurmann P, Ibarra-Cortez SH, Dave AS, Valderrábano M. Retrograde coronary venous ethanol infusion for ablation of refractory ventricular tachycardia. Circ Arrhythmia Electrophysiol 2016; 9: e004352. Go to original source... Go to PubMed...
  40. Cuculich PS, Schill MR, et al. Noninvasive cardiac radiation for ablation of ventricular tachycardia. N Engl J Med 2017; 377: 2325-2336. Go to original source... Go to PubMed...
  41. Anter E, Hutchinson MD, Deo R, et al. Surgical ablation of refractory ventricular tachycardia in patients with nonischemic cardiomyopathy. Circ Arrhythmia Electrophysiol 2011; 4: 494-500. Go to original source... Go to PubMed...
  42. Calkins H, Epstein A, Packer D, et al. Catheter ablation of ventricular tachycardia in patients with structural heart disease using cooled radiofrequency energy: results of a prospective multicenter study. Cooled RF Multi Center Investigators Group. J Am Coll Cardiol 2000; 35: 1905-1914. Go to original source... Go to PubMed...
  43. Peichl P, Wichterle D, Pavlu L, Cihak R, Aldhoon B, Kautzner J. Complications of catheter ablation of ventricular tachycardia: a single-center experience. Circ Arrhythmia Electrophysiol 2014; 7: 684-690. Go to original source... Go to PubMed...
  44. Palaniswamy C, Kolte D, Harikrishnan P, et al. Catheter ablation of postinfarction ventricular tachycardia: Ten-year trends in utilization, in-hospital complications, and in-hospital mortality in the United States. Hear Rhythm 2014; 11: 2056-2063. Go to original source... Go to PubMed...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.